Endosomolytic Peptides Enable the Cellular Delivery of Peptide Nucleic Acids
Name
d4cc05214e.pdf
Size
838.06 KB
Format
Adobe PDF
Checksum (MD5)
8dc375b16082f6bdca061a044e4fb0f8
Author(s)
Giancola, JoLynn B.
Raines, Ronald T.
Date Issued
November 11, 2024
Journal
ChemComm
Publisher
Royal Society of Chemistry
Citation
J. B. Giancola and R. T. Raines, “Endosomolytic Peptides Enable the Cellular Delivery of Peptide Nucleic Acids,” Chemical Communications 60 (2024): 15019–15022.
Version
Final published version
Abstract
Precision genetic medicine enlists antisense oligonucleotides (ASOs) to bind to nucleic acid targets important for human disease. Peptide nucleic acids (PNAs) have many desirable attributes as ASOs but lack cellular permeability. Here, we use an assay based on the corrective splicing of an mRNA to assess the ability of synthetic peptides to deliver a functional PNA into a human cell. We find that the endosomolytic peptides L17E and L17ER4 are highly efficacious delivery vehicles. Co-treatment of a PNA with low micromolar L17E or L17ER4 enables robust corrective splicing in nearly all treated cells. Peptide–PNA conjugates are even more effective. These results enhance the utility of PNAs as research tools and potential therapeutic agents.
MIT Department
Massachusetts Institute of Technology. Department of Chemistry
Terms of Use
Creative Commons Attribution-Noncommercial
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1039/D4CC05214E
